(Q39985777)

English

Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin (English)

1 reference

Europe PubMed Central

16 September 2017

0 references

2

1 reference

Europe PubMed Central

16 September 2017

5

object named as

Gabor Halmos

1 reference

Europe PubMed Central

16 September 2017

Karoly Szepeshazi

1

object named as

Karoly Szepeshazi

1 reference

Europe PubMed Central

16 September 2017

3

object named as

Andrea Treszl

1 reference

Europe PubMed Central

16 September 2017

author name string

Stephan Seitz

4

1 reference

Europe PubMed Central

16 September 2017

publication date

1 April 2008

1 reference

Europe PubMed Central

16 September 2017

Anti-Cancer Drugs

1 reference

Europe PubMed Central

16 September 2017

19

1 reference

Europe PubMed Central

16 September 2017

4

1 reference

Europe PubMed Central

16 September 2017

349-358

1 reference

Europe PubMed Central

16 September 2017

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

New therapies for hepatocellular carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hepatocellular carcinoma: the need for progress.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Octreotide for cancer of the liver and biliary tree

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hepatocellular carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hepatocellular carcinoma: recent trends in the United States

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hepatocellular carcinoma: are we making progress?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

International trends and patterns of primary liver cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Growth factor induced mitogenic effects and inositol phosphate responses in primary hepatocyte cultures from normal rat liver and rat liver nodules.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Management of hepatocellular cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Practical management of hepatocellular carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Hepatocellular carcinoma: an overview

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Emerging drugs for hepatocellular carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Synergistic effects of bombesin and epidermal growth factor on cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Radiation therapy for hepatocellular carcinoma: from palliation to cure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Complete, Long-Standing Regression of Hepatocellular Carcinoma After Somatostatin Analogue Treatment

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

A chemically labeled cytotoxic agent: two-photon fluorophore for optical tracking of cellular pathway in chemotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/CAD.0B013E3282F9ADCE

Identifiers

10.1097/CAD.0B013E3282F9ADCE

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39985777&oldid=2119256485"